| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | Heidbreder Christian Chief Scientific Officer | Sale | -18,586 | -7.54%227,923 | $38.06 | $707,383 | View SEC filing | |
| 2026-06-10 | Preblick Ryan Chief Financial Officer | Sale | -36,000 | -11.22%284,751 | $37.70 | $1,357,200 | View SEC filing | |
| 2026-03-13 | Ryan Barbara Director | Purchase | +8 | +0.14%5,724 | $31.09 | $249 | View SEC filing | |
| 2026-03-11 | Ryan Barbara Director | Purchase | +31 | +0.55%5,716 | $32.56 | $1,009 | View SEC filing | |
| 2026-03-11 | Kingsley Stuart A Director | Purchase | +940 | +20.25%5,582 | $31.86 | $29,953 | View SEC filing | |
| 2026-01-07 | Humphreys Keith Director | Purchase | +775 | +15.42%5,802 | $35.39 | $27,429 | View SEC filing | |
| 2026-01-07 | Ryan Barbara Director | Purchase | +775 | +65.24%1,963 | $35.39 | $27,429 | View SEC filing | |
| 2026-01-07 | Wheadon David E. Director | Purchase | +1,771 | +14.03%14,395 | $35.39 | $62,680 | View SEC filing | |
| 2026-01-07 | Stejbach Mark Director | Purchase | +775 | +4.82%16,847 | $35.39 | $27,429 | View SEC filing | |
| 2026-01-07 | NINIVAGGI DANIEL A Director | Purchase | +775 | +4.80%16,923 | $35.39 | $27,429 | View SEC filing |
1-10 of 10